These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1698719

  • 1. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
    Fuchs M, Henkel P, Becker-Scheid D, Schmitt J.
    Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P, Langsteger W, Lind P, Klima G, Pierer G, Reisecker F, Eber O.
    Acta Med Austriaca; 1991 Aug; 18 Suppl 1():20-2. PubMed ID: 1719728
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
    Koscielny J, Jung F, Mrowietz C, Pindur G, Förster H, Schimetta W, Kiesewetter H, Wenzel E.
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
    [Abstract] [Full Text] [Related]

  • 8. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
    Staedt U, Hütt M, Herrmann B, Seufzer U, Leweling H.
    Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
    [Abstract] [Full Text] [Related]

  • 9. [Effect of hemodilution on systemic and capillary hematocrit].
    Jung F, Koscielny J, Mrowietz C, Wolf S, Kiesewetter H, Wenzel E.
    Infusionstherapie; 1990 Oct; 17(5):268-75. PubMed ID: 1705247
    [Abstract] [Full Text] [Related]

  • 10. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F, Waldhausen P, Spitzer S, Mrowietz C, Häuser B, Wenzel E.
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [Abstract] [Full Text] [Related]

  • 11. [Effects of hydroxyethyl-starch on hemorheology in patients with chronic liver disease].
    Lao JX, Gu MN, Xiao JF, Lu XM.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Apr; 25(4):438-40. PubMed ID: 15837650
    [Abstract] [Full Text] [Related]

  • 12. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M, Brechtelsbauer H, Akbulut C, Fett W, Briegel J, Finsterer U.
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [Abstract] [Full Text] [Related]

  • 13. [Conjunctival oxygen partial pressure, hemorheology and circulatory parameters in acute cerebral infarct before and following infusion of 6 percent low molecular hydroxyethyl starch].
    Kortsik CS, Staedt U, Stein T, Geiger G, Buss J.
    Infusionstherapie; 1990 Apr; 17(2):79-82. PubMed ID: 1693909
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
    Treib J, Haass A, Pindur G, Grauer MT, Jung F, Wenzel E, Schimrigk K.
    Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
    [Abstract] [Full Text] [Related]

  • 18. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
    Treib J, Haass A, Pindur G, Seyfert UT, Treib W, Grauer MT, Jung F, Wenzel E, Schimrigk K.
    Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
    [Abstract] [Full Text] [Related]

  • 19. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
    Winter V, Gille J, Richter A, Sablotzki A, Wiedemann B.
    Anesteziol Reanimatol; 2006 Dec; (2):43-7. PubMed ID: 16758944
    [Abstract] [Full Text] [Related]

  • 20. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
    Scheffler P, Jung F, Mrowietz C, Waldhausen P, Leipnitz G, Häuser B.
    Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.